Skip to content

To see add on effect of kantakari vati in essential hypertension

A Ranadomized controlled trial to evaluate an add on effect of kantakari Vati with ARBs with or without diuretic in managemant of Essential Hypertension - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079564
Enrollment
66
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr Priya Pravin Shevale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having Stage I hypertension, isolated systolic and isolated diastolic hypertension. 2.Age of the patient between 20 to 60 years. 4. Shirashool, Klama, Hridspandana, Bhrama patient having these symptoms of Hypertension will be included in the clinical study. 5. Patients taking Angiotensin Receptor Blockers with or without diuretic and still having raised blood pressure. 6.Diabetic patients with ongoing allopathy medications only. 7.Patient on previous ayurvedic medications, 7 days washout period will be given to avoid drug interaction. 8. Patients having serum creatinine level less than 1.4 mg/dl.

Exclusion criteria

Exclusion criteria: 1.Patients having Stage II, hypertensive crisis will be excluded. 2.Patient suffering from any other serious systemic illness like Acute cerebrovascular diseases, Acute coronary syndrome, Acute Haemorrhagic conditions, Acute septic shock etc. 3.Secondary Hypertension or Accelerated Hypertension. 4. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To evaluate the add on effect of Kantakari Vati with ARBs with or without diuretic in Vyanodan kala in decreasing the sign and symptoms of essential hypertension in duration of 30 days.Timepoint: inclusion day,15th day,30th day

Secondary

MeasureTime frame
1. To study the Ayurveda concepts of Hypertension. 2. To see add on effect of Kantakari Vati in Essential Hypertension.Timepoint: Inclusion day,15th day,30th day

Countries

India

Contacts

Public ContactDr Priya Pravin Shevale

MAMs Sumatibhai Shah Ayurved Mahavidyalaya Hadapsar

priyashevale4@gmail.com08484830574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026